Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Adami, Eleonora Dr. (3) Akalin, Altuna Dr. (5) Altmueller, Janine Dr.med. (3) Barke, Niclas (1) Beule, Dieter Dr. (9) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blachut, Susanne (1) Blankenstein, Thomas Prof. Dr. (2) Blume, Alexander Dr. (1) Blüthgen, Nils (6) Borodina, Tatiana Dr. (2) Chen, Wei Prof. Dr. (3) Conrad, Thomas Dr. (1) Del Giudice, Simone (2) Deter, Aylina (1) Diecke, Sebastian Dr. (1) Falcke, Martin Prof. Dr. (1) Faxel, Miriam (1) Franke, Vedran Dr. (4) Freimuth, Jonas (1) Fritsche, Raphaela Dr. (1) Golusik, Sabrina (1) Gotthardt, Michael Prof. Dr. (2) Graf, Robin Dr. (1) Grobe, Jenny (1) Haas, Simon Dr. rer. nat. (1) Haghverdi, Laleh Dr. (1) Heinemann, Udo Prof. Dr. (3) Herzog, Margareta (1) Hinz, Michael Dr. (1) Hinze, Christian Dr. med. Dipl.-Math. (2) Hirsekorn, Antje (1) Hübner, Norbert Prof. Dr. (5) Hummel, Oliver (1) Janz, Martin Dr. (1) Junker, Jan Philipp Prof. Dr. (1) Kastelic, Nicolai (4) Keller, Ulrich Dr. med. (3) Kempa, Stefan Dr. (7) Kirchner, Marieluise Dr. (3) Kocks, Christine Dr. (6) Kunz, Severine Dr. (1) Lahmann, Ines Dr. (1) Landthaler, Markus Prof. Dr. (119) Lindberg, Eric Lars-Helge (1) Maatz, Henrike Dr. (3) Mastrobuoni, Guido Dr. (7) Mathas, Stephan Dr. (1) Mertins, Philipp Dr. (2) Minia, Igor Dr. (5) Mintcheva, Janita (1) Neuschulz, Anika (1) Obermayer-Wasserscheid, Benedikt Dr. (14) Ohler, Uwe Prof. Dr. (10) Oliveras Martinez, Anna Dr. (1) Patone, Giannino Dr. (1) Paul, Friedemann Prof. Dr. med. (1) Pezzutto, Antonio Prof. Dr. (1) Quedenau, Claudia (3) Radke, Michael Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (19) Rybak-Wolf, Agnieszka Dr. (3) Scharek, Nadine (1) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (4) Schütz, Anja Dr. (3) Selbach, Matthias Prof. Dr. (15) Spanjaard, Bastiaan Dr. (1) Sprink, Thiemo Dr. (1) Strzelecka, Paulina Maria (1) Teixeira Alves, Luiz Gustavo Dr. (7) Uyar, Bora Dr. (1) Villamil, Gabriel (1) Walther, Wolfgang Prof. Dr. (1) Wanker, Erich Prof. Dr. (2) Wei, Tzu Ting (1) Woehler, Andrew Dr. (1) Wolf, Jana Prof. Dr. (1) Wurmus, Ricardo (2) Wyler, Emanuel Dr. (56) Zauber, Henrik Dr. (3) Zenkner, Martina (1) (-) Chekulaeva, Marina Dr. (2) (-) Na, Il-Kang Dr. (69) (-) Schwarz, Roland Dr. (1) Bioinformatics and Omics Data Science (2) Bioinformatik der Genregulation (3) Biologie maligner Lymphome (1) Entwicklung Mechanismus-basierter Krebstherapien (3) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (2) Epigenetische Modifikationen in Neuroblastom (2) Epigenetische Regulation und Chromatinstruktur (1) Experimentelle Ultrahochfeld-MR (20) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genomics (2) (-) Immundysregulationen in der Onkologie (69) Kardiale MRT (4) Magnetic Resonance (20) Molekulare Immunologie und Gentherapie (2) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (21) Proteom Dynamik (3) Proteomics (1) (-) RNA Biologie und Posttranscriptionale Regulation (3) Systembiologie von Gen-regulatorischen Elementen (3) Systemische Hämatologie, Stammzellen & Präzisionsmedizin (1) Systems Biology Imaging (2) Translational Bioinformatics (7) Translationale Onkologie solider Tumore (1) Tumorgenetik und zelluläre Stressantworten (3) 2001 (1) 2002 (1) 2003 (2) 2005 (3) 2006 (3) 2007 (2) 2008 (3) 2009 (3) 2010 (5) 2011 (2) 2013 (4) 2014 (2) 2015 (6) 2016 (2) 2017 (2) 2018 (4) 2019 (4) 2020 (3) 2021 (7) 2022 (8) 2023 (4) 2024 (1) 72 Ergebnisse: Active Filter: Chekulaeva, Marina Dr.Na, Il-Kang Dr.Schwarz, Roland Dr.Immundysregulationen in der OnkologieRNA Biologie und Posttranscriptionale Regulation Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. März 2005 / Blood Cells Mol Dis Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor M. Holdhoff K.A. Kreuzer C. Appelt R. Scholz I.K. Na B. Hildebrandt H. Riess A. Jordan C.A. Schmidt R.A. Van Etten B. Doerken P. LeCoutre 01. März 2005 / Leuk Res Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML I.K. Na K.A. Kreuzer J. Lupberger B. Doerken P. Coutre 01. August 2022 / eJHaem Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls N. Winkelmann M. Schwarz B. Hildebrandt O. Henke L. Bullinger I.K. Na S. Stintzing P. le Coutre 10. Februar 2023 / Front Immunol Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation B. Obermayer L. Keilholz T. Conrad M. Frentsch I.W. Blau L. Vuong S. Lesch K. Movasshagi C. Tietze-Stolley L. Loyal L. Henze O. Penack U. Stervbo N. Babel S. Haas D. Beule L. Bullinger Friedrich Wittenbecher I.K. Na 01. Juni 2023 / J Clin Oncol Consensus molecular subtypes as biomarkers of fluorouracil and folinic acid maintenance therapy with or without panitumumab in (RAS) wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212) A. Stahler B. Hoppe I.K. Na L. Keilholz L. Müller M. Karthaus S. Fruehauf U. Graeven L. Fischer von Weikersthal E. Goekkurt S. Kasper A.J. Kind A. Kurreck A.H.S. Alig S. Held A. Reinacher-Schick V. Heinemann D. Horst A. Jarosch S. Stintzing T. Trarbach D.P. Modest 27. Dezember 2018 / Blood Nrf2 regulates CD4(+) T cell-induced acute graft-versus-host disease in mice J.J. Tsai E. Velardi Y. Shono K.V. Argyropoulos A.M. Holland O.M. Smith N.L. Yim U.K. Rao F.M. Kreines S.R. Lieberman L.F. Young A. Lazrak S. Youssef Y.Y. Fu C. Liu C. Lezcano G.F. Murphy I.K. Na R.R. Jenq A.M. Hanash J.A. Dudakov M.R.M. van den Brink 25. April 2022 / OncoImmunology Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade G. Kofla C. Radecke M. Frentsch W. Walther S. Stintzing H. Riess L. Bullinger I.K. Na 29. Mai 2022 / Gut Microbes Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma M. Schmiester R. Maier R. Riedel P. Durek M. Frentsch S. Kolling M.F. Mashreghi R. Jenq L. Zhang C.B. Peterson L. Bullinger H.D. Chang I.K. Na 23. Mai 2022 / Front Immunol Paired donor and recipient immunophenotyping in allogeneic hematopoietic stem cell transplantation: a cellular network approach F. Wittenbecher S. Lesch S. Kolling I.W. Blau L. Vuong F. Borchert K. Movasshagi C. Tietze-Bürger O. Penack J. Ahn L. Bullinger M. Frentsch I.K. Na 01. Februar 2022 / Eur J Cancer Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial C.A. Peuker S. Yaghobramzi C. Grunert L Keilholz E. Gjerga S. Hennig S. Schaper I.K. Na U. Keller S. Brucker T. Decker P. Fasching T. Fehm W. Janni S. Kümmel A. Schneeweiss M. Schuler D. Lüftner A. Busse Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Seite 4 … Nächste Seite Next › Letzte Seite Last »
01. März 2005 / Blood Cells Mol Dis Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor M. Holdhoff K.A. Kreuzer C. Appelt R. Scholz I.K. Na B. Hildebrandt H. Riess A. Jordan C.A. Schmidt R.A. Van Etten B. Doerken P. LeCoutre
01. März 2005 / Leuk Res Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML I.K. Na K.A. Kreuzer J. Lupberger B. Doerken P. Coutre
01. August 2022 / eJHaem Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls N. Winkelmann M. Schwarz B. Hildebrandt O. Henke L. Bullinger I.K. Na S. Stintzing P. le Coutre
10. Februar 2023 / Front Immunol Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation B. Obermayer L. Keilholz T. Conrad M. Frentsch I.W. Blau L. Vuong S. Lesch K. Movasshagi C. Tietze-Stolley L. Loyal L. Henze O. Penack U. Stervbo N. Babel S. Haas D. Beule L. Bullinger Friedrich Wittenbecher I.K. Na
01. Juni 2023 / J Clin Oncol Consensus molecular subtypes as biomarkers of fluorouracil and folinic acid maintenance therapy with or without panitumumab in (RAS) wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212) A. Stahler B. Hoppe I.K. Na L. Keilholz L. Müller M. Karthaus S. Fruehauf U. Graeven L. Fischer von Weikersthal E. Goekkurt S. Kasper A.J. Kind A. Kurreck A.H.S. Alig S. Held A. Reinacher-Schick V. Heinemann D. Horst A. Jarosch S. Stintzing T. Trarbach D.P. Modest
27. Dezember 2018 / Blood Nrf2 regulates CD4(+) T cell-induced acute graft-versus-host disease in mice J.J. Tsai E. Velardi Y. Shono K.V. Argyropoulos A.M. Holland O.M. Smith N.L. Yim U.K. Rao F.M. Kreines S.R. Lieberman L.F. Young A. Lazrak S. Youssef Y.Y. Fu C. Liu C. Lezcano G.F. Murphy I.K. Na R.R. Jenq A.M. Hanash J.A. Dudakov M.R.M. van den Brink
25. April 2022 / OncoImmunology Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade G. Kofla C. Radecke M. Frentsch W. Walther S. Stintzing H. Riess L. Bullinger I.K. Na
29. Mai 2022 / Gut Microbes Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma M. Schmiester R. Maier R. Riedel P. Durek M. Frentsch S. Kolling M.F. Mashreghi R. Jenq L. Zhang C.B. Peterson L. Bullinger H.D. Chang I.K. Na
23. Mai 2022 / Front Immunol Paired donor and recipient immunophenotyping in allogeneic hematopoietic stem cell transplantation: a cellular network approach F. Wittenbecher S. Lesch S. Kolling I.W. Blau L. Vuong F. Borchert K. Movasshagi C. Tietze-Bürger O. Penack J. Ahn L. Bullinger M. Frentsch I.K. Na
01. Februar 2022 / Eur J Cancer Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial C.A. Peuker S. Yaghobramzi C. Grunert L Keilholz E. Gjerga S. Hennig S. Schaper I.K. Na U. Keller S. Brucker T. Decker P. Fasching T. Fehm W. Janni S. Kümmel A. Schneeweiss M. Schuler D. Lüftner A. Busse